Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -5.00 (-2.94%)
Spread: 10.00 (6.25%)
Open: 170.00
High: 170.00
Low: 165.00
Prev. Close: 170.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing and Subscription

9 Mar 2021 07:00

RNS Number : 5602R
Helios Underwriting Plc
09 March 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

09 March 2021

Helios Underwriting plc

("Helios", "Company" or the "Group")

 

Result of Placing and Subscription

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, is pleased to announce that, following the announcement released on 8 March 2021 ("Announcement"), it has successfully raised gross proceeds of approximately £53.5 million through a placing of, and a subscription for, an aggregate of 33,412,625 New Ordinary Shares at a price of £1.60 per share.

 

A total of 6,037,625 New Ordinary Shares have been placed at the Issue Price with existing and new investors pursuant to the Placing, thereby raising approximately £9.7 million, subject to Shareholder approval.

 

In addition, a total of 27,375,000 New Ordinary Shares have been subscribed for under the Subscription at the Issue Price, thereby raising £43.8 million, subject to Shareholder approval.

 

The Announcement also confirmed that the Company proposes to raise up to a further approximately £3.0 million by way of a conditional open offer of 1,861,787 Open Offer Shares to Qualifying Shareholders at the Issue Price, subject to Shareholder approval.

 

The Placing, Subscription and Open Offer are all conditional, inter alia, upon the passing of certain Resolutions. Accordingly, the Circular is expected to be posted later today, notifying Shareholders of the General Meeting on 1 April 2021. Due to the need to observe the UK Government's current guidance on social distancing and in light of the laws restricting individuals' ability to meet with others to help prevent the spread of Covid-19, this general meeting will be held behind closed doors. Accordingly, the Board will ensure a quorum is present but regrettably no additional Shareholders will be able to attend the General Meeting. This is essential to ensure the General Meeting's proper conduct and safe operation.

 

The Placing was conducted by way of an accelerated book build process. Shore Capital acted as sole broker on the Placing.

 

The Issue Price represents a discount of approximately 17.9 per cent. to the closing price of £1.95 per share on 8 March 2020 and a premium of 6.0 per cent. to the Company's pro-forma adjusted net asset value of £1.51 per share as at 30 June 2020, announced on 16 February 2021.

 

An application will be made for the admission of the Placing Shares, the Subscription Shares and the Open Offer Shares to trading on AIM and dealings in the Placing Shares, Subscription Shares and Open Offer Shares are expected to commence at 8.00 a.m. on 9 April 2021 (or such later date, being not later than 8.00 a.m. on 30 April 2021, as the Company and Shore Capital may agree). The Placing Shares and the Subscription Shares, when issued, will rank pari passu with the Existing Ordinary Shares.

 

Related Party Transaction

Polar Capital has agreed to subscribe for 4,875,000 Placing Shares. As at the date of this announcement, Polar Capital holds 5,000,000 Existing Ordinary Shares representing approximately 14.9 per cent. of the Existing Ordinary Shares. As such, Polar Capital is a substantial shareholder of the Company and its participation in the Placing is a related party transaction pursuant to AIM Rule 13 of the AIM Rules.

 

The Directors consider, having consulted with the Company's nominated adviser, Shore Capital, that the terms of Polar Capital's participation in the Placing is considered fair and reasonable insofar as the Shareholders are concerned.

 

A copy of the Circular will shortly be available on the Company's website at www.huwplc.com.

 

Nigel Hanbury, Chief Executive of Helios, commented:

"This is a period of unprecedented opportunity for Helios, with a hardening market coupled with the opportunities we see to make further LLV acquisitions which would be value enhancing for our shareholders. Helios is uniquely positioned to capitalise on these opportunities. We are delighted with the results of the fundraise and thank our existing shareholders for their support and welcome our new investors." 

 

All capitalised terms in this announcement are as defined in the Company's Announcement.

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (ED No.596/2014) (and all delegated regulations, implementation directives, technical standards and guidance issued by European Securities and Markets Authority from time to time, as implemented in the UK by the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal) Act 2020))("UK MAR"), encompassing information relating to the Placing, the Subscription and the Open Offer as described above, and is disclosed in accordance with the Company's obligations under Article 17 of UK MAR.

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

Quentin Perrot +44 (0)20 3124 6499

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROISSFEFAEFSEID
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.